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Abstract
The Ypd1 phosphorelay protein is a central constituent of fungal two-component signal
transduction pathways. Inhibition of Ypd1 in Saccharomyces cerevisiae and Cryptococcus
neoformans is lethal due to the sustained activation of the ‘p38-related’ Hog1 stress-acti-
vated protein kinase (SAPK). As two-component signalling proteins are not found in ani-
mals, Ypd1 is considered to be a prime antifungal target. However, a major fungal pathogen
of humans, Candida albicans, can survive the concomitant sustained activation of Hog1 that
occurs in cells lacking YPD1. Here we show that the sustained activation of Hog1 upon
Ypd1 loss is mediated through the Ssk1 response regulator. Moreover, we present evidence
that C. albicans survives SAPK activation in the short-term, following Ypd1 loss, by trigger-
ing the induction of protein tyrosine phosphatase-encoding genes which prevent the
accumulation of lethal levels of phosphorylated Hog1. In addition, our studies reveal an
unpredicted, reversible, mechanism that acts to substantially reduce the levels of phosphor-
ylated Hog1 in ypd1Δ cells following long-term sustained SAPK activation. Indeed, over
time, ypd1Δ cells become phenotypically indistinguishable from wild-type cells. Importantly,
we also find that drug-induced down-regulation of YPD1 expression actually enhances the
virulence of C. albicans in two distinct animal infection models. Investigating the underlying
causes of this increased virulence, revealed that drug-mediated repression of YPD1 expres-
sion promotes hyphal growth both within murine kidneys, and following phagocytosis, thus
increasing the efficacy by which C. albicans kills macrophages. Taken together, these find-
ings challenge the targeting of Ypd1 proteins as a general antifungal strategy and reveal
novel cellular adaptation mechanisms to sustained SAPK activation.
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Author summary
As fungi-attributed human deaths are increasing, there is an urgent need to develop new
antifungal treatments. Two-component related proteins, such as the Ypd1 phosphorelay
protein, have been heralded as antifungal targets as they are not found in humans and
because inactivation of YPD1 in several different fungi causes sustained SAPK activation
and cell death. However, we have discovered that inactivation of YPD1 in the major
human pathogen, Candida albicans, actually enhances virulence. Furthermore, we reveal
that this fungus adapts to the sustained activation of the Hog1 SAPK triggered by Ypd1
loss by mounting distinct mechanisms that actively reduce the level of phosphorylated
Hog1. These findings question the validity of Ypd1 proteins as broad-spectrum antifungal
targets and provide insights into the cellular adaptation to sustained SAPK activation.
Introduction
Candida albicans is the leading cause of systemic fungal infections in humans resulting in over
400,000 deaths each year in immuno-compromised patients [1]. The ability of C. albicans to
adapt to host-imposed stresses encountered during infection is an important virulence trait
[2]. Central to fungal stress responses are the stress-activated protein kinases (SAPKs), which
are conserved eukaryotic signalling enzymes that allow cells to adapt to environmental change
[3, 4]. In C. albicans, the Hog1 SAPK is activated in response to diverse, physiologically rele-
vant, stress conditions, and cells lacking Hog1 are acutely sensitive to such stresses [5–7]. Con-
sistent with the vital role of the Hog1 SAPK in stress survival, C. albicans cells lacking HOG1
display significantly attenuated virulence in systemic, commensal, and phagocyte infection
models [8–11].
All SAPK activation mechanisms reported to date result in the phosphorylation of con-
served threonine and tyrosine residues located within the TGY motif of the catalytic domain
of the kinase [3]. Such pathways are tightly regulated as the nature of the response is dependent
on the extent and period of SAPK activation. For example, in the model yeast Saccharomyces
cerevisiae, transient activation of the Hog1 SAPK is vital to survive osmotic stress [4], whereas
sustained activation triggers programmed cell death [12]. Similarly in human cells transient
activation of the p38 SAPK promotes stress-induced gene expression and cellular proliferation
[13], whereas sustained SAPK activation triggers apoptosis [14]. In contrast, much less is
known regarding the regulation and cellular consequences of sustained SAPK activation in C.
albicans.
Despite the availability of several antifungal drugs, the high mortality rate associated with
C. albicans systemic infections and the emergence of drug resistant strains highlights the
urgent clinical need for new anti-fungal therapies [15]. Although Hog1 is an essential virulence
determinant in C. albicans, the conservation with highly related SAPKs in human cells suggests
that Hog1 itself may be unsuitable as an antifungal target. Instead, there has been much inter-
est in identifying fungal-specific regulators of SAPKs as potential drug targets. Candidate tar-
gets include two-component related phosphorelay systems which constitute an important
mechanism employed by fungi, but not mammals, to sense and relay specific stress signals to
SAPK modules [16]. In S. cerevisiae, this system is comprised of a hybrid histidine kinase
(Sln1), an intermediary phosphorelay protein (Ypd1), and a response regulator protein (Ssk1)
(Fig 1). Following osmotic stress, the Sln1 histidine kinase is inactivated, which halts phos-
phorelay through Ypd1, and consequently leads to the rapid dephosphorylation of Ssk1 [17].
Dephosphorylated Ssk1 is a potent activator of the Ssk2/Ssk22 MAPKKKs which regulate
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Hog1 activation [18, 19]. Significantly, loss of either Sln1 or Ypd1 function in S. cerevisiae is
lethal [20], due to the accumulation of unphosphorylated Ssk1 and the resulting sustained
Hog1 activation which triggers apoptosis-mediated cell death [12]. It is likely that sustained
Hog1 activation can also not be tolerated in the human fungal pathogen, Cryptococcus neofor-
mans, as Ypd1 is essential for the viability of cells containing Hog1 [21]. The essential nature
of Ypd1 in these fungi, and the many reports illustrating the importance of two-component
proteins in fungal pathogenicity, has fuelled interest in targeting Ypd1 for antifungal drug
development (reviewed in [22]).
C. albicans has seven two-component proteins; three histidine kinases (Sln1, Chk1, Nik1),
three response regulators (Ssk1, Skn7, Crr1/Srr1), and a single phosphorelay protein (Ypd1)
[23]. In S. cerevisiae, Ypd1 plays a pivotal role in mediating all phosphorelay events from the
upstream histidine kinases to the downstream Ssk1 and Skn7 response regulators [17, 24],
Fig 1. Overview of two component-mediated regulation of the Hog1 SAPK in S. cerevisiae. Under non-
stress conditions the Sln1 histidine kinase autophosphorylates, and this phosphate is transferred via the Ypd1
phosphorelay protein to the Ssk1 response regulator protein. Following osmotic stress Sln1 is inactivated,
thus halting the phosphorelay which culminates in unphosphorylated Ssk1 which is a potent activator of the
Ssk2 MAPKKK. This results in the phosphorylation and activation of the downstream Hog1 SAPK.
doi:10.1371/journal.ppat.1006131.g001
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which supports the concept that Ypd1 is an appropriate antifungal target. Hence, in this study,
we investigated the impact of inactivating Ypd1 upon stress signalling and virulence of C. albi-
cans. As reported recently, we found that C. albicans can survive deletion of YPD1 [25]. Here
we extend this finding by illustrating that C. albicans survives the sustained SAPK activation
following Ypd1 loss by evoking multiple mechanisms to reduce the level of phosphorylated
Hog1. Furthermore, we demonstrate that inactivation of Ypd1 during infection actually
increases the virulence of C. albicans in a number of infection models, revealing that Ypd1
may not be a suitable target for anti-fungal drug development.
Results
Repression or deletion of YPD1 in C. albicans induces sustained Hog1
activation
C. albicans contains a single homologue of the S. cerevisiae phosphorelay protein Ypd1 [26].
Although deletion of Ypd1 results in a lethal phenotype in both S. cerevisiae and C. neoformans
[20, 21], a recent study revealed that YPD1 is not an essential gene in C. albicans, with ypd1Δ
cells instead displaying a slow growth phenotype [25]. To investigate this further we created a
C. albicans strain, tetO-YPD1 (Fig 2A), in which one allele of YPD1 was deleted and the
remaining allele placed under the control of a doxycycline-repressible promoter [27]. North-
ern analysis confirmed that treatment of tetO-YPD1 cells with doxycycline caused a rapid
decrease in YPD1 mRNA levels (Fig 2B). However, whilst repression of YPD1 expression did
result in a slower growth rate (Fig 2C, upper panel), the cells were viable. Furthermore, consis-
tent with the previous study [25], we were able to generate a viable homozygous ypd1Δ null
mutant which displayed a slower growth rate compared to wild-type cells (Fig 2C, lower
panel).
Deletion of YPD1 is lethal in S. cerevisiae due to constitutive SAPK activation. Consistent
with previous findings [25], we found that repression of YPD1 expression in tetO-YPD1 cells
(Fig 2D, upper panel; S1 Fig), or deletion of YPD1 (Fig 2D, lower panel), also stimulated high
levels of Hog1 phosphorylation in C. albicans. Together these data indicate that the inhibitory
effect of YPD1 on SAPK activation in S. cerevisiae is conserved in C. albicans. However, it was
possible that the phosphorylated Hog1 detected did not result in activation of Hog1-dependent
downstream events. To test this possibility the expression levels of the Hog1-dependent genes,
GPD2 and RHR2 [28], important for glycerol biosynthesis were examined upon repression or
deletion of YPD1 (Fig 2E). Both genes were found to be up-regulated and, furthermore, as
expected, increased intracellular glycerol concentrations were observed in ypd1Δ cells in the
absence of stress (Fig 2F). Thus collectively, these data confirm that the phosphorylated Hog1
kinase triggered by inactivation of Ypd1 in C. albicans is active. However, in contrast to S. cere-
visiae and C. neoformans constitutive Hog1 activation does not result in loss of viability in C.
albicans.
Phenotypes associated with loss of Ypd1 are dependent on Hog1 and
Ssk1
Analyses of cells with loss of Ypd1 function, either by repression or deletion of the YPD1 gene,
revealed identical morphological abnormalities and stress-resistance profiles. For example,
loss of YPD1 resulted in swollen pseudohyphal-like cells (Fig 3A), possibly due to the increased
intracellular levels of the osmolyte glycerol that occurs upon inactivation of Ypd1 (Fig 2F). In
addition, as reported previously [25], cells lacking Ypd1 were highly flocculent as demon-
strated by their rapid sedimentation rate (Fig 3A). Interestingly, cells lacking Ypd1 displayed
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acute sensitivity to sodium arsenite, increased resistance to the organic peroxide tert-butyl
hydroperoxide (t-BOOH), and wild-type levels of resistance to osmotic stress (Fig 3B). Loss of
YPD1 also resulted in increased sensitivity to the cell wall perturbing agent calcofluor white
(Fig 3B). This is consistent with Hog1 activation in ypd1Δ cells (Fig 2D), as hog1Δ cells display
significant resistance to this drug [6].
Loss of Ypd1 function is predicted to perturb phosphorelay to all three response regulator
proteins in C. albicans; Ssk1, Skn7 and Crr1/Srr1 [23, 29, 30]. In S. cerevisiae it is the accumula-
tion of the unphosphorylated Ssk1 response regulator which triggers hyperactivation of the
Hog1 SAPK [18]. Hence, to investigate which phenotypes associated with Ypd1 loss in C. albi-
cans were due to Ssk1-mediated activation of Hog1, hog1Δ ypd1Δ and ssk1Δ ypd1Δ double
mutant strains were created. All of the ypd1Δ-associated phenotypes, described above, were
found to be dependent on both Hog1 and Ssk1. For example, the swollen pseudohyphal-like
morphology associated with ypd1Δmutant cells was repressed in the absence of either HOG1
Fig 2. C. albicans cells lacking YPD1 exhibit hyperactivation of Hog1 but are viable. (A) Strategy to control YPD1 expression.
One YPD1 allele was deleted, and the remaining allele placed under the control of the E. coli tet operator (tetO) in strain THE1 to
generate strain tetO-YPD1 (JC1586). THE1 cells express an E. coli tet repressor–S. cerevisiae Hap4 activation domain fusion
protein. In the absence of doxycycline (DOX), this fusion protein binds as a dimer to the tet operator resulting in transcriptional
activation. However, doxycycline prevents dimerisation of the fusion protein and blocks transcription. (B) Doxycycline treatment
inhibits YPD1 expression. Northern analysis of YPD1 and ACT1 (control) transcript levels in tetO-YPD1 cells treated with doxycycline
for the indicated times. (C) Repression or deletion of YPD1 results in a slow growth phenotype. Growth analysis of tetO-YPD1 cells,
untreated or treated with doxycycline (top panel), and wild-type (Wt, JC21), ypd1Δ (JC2001) and ypd1Δ+YPD1 (JC2002) cells
(bottom panel). (D) Repression or deletion of YPD1 results in constitutive phosphorylation of Hog1. Western blot analysis of whole
cell extracts isolated from tetO-YPD1 cells following treatment with doxycycline for the indicated times, or from exponentially growing
wild-type (Wt), ypd1Δ and ypd1Δ+YPD1 cells. Blots were probed for phosphorylated Hog1 (Hog1-P), stripped and reprobed for total
Hog1 (Hog1). (E) Repression or deletion of YPD1 results in high levels of GPD2 and RHR2 expression. RNA was isolated from
tetO-YPD1 cells, treated with or without doxycycline for the indicated times, or wild-type and ypd1Δ cells, and analyzed using gene-
specific probes with ACT1 as a loading control. (F) Deletion of YPD1 results in increased intracellular glycerol levels. The mean ± SD
is shown for 3 biological replicates.
doi:10.1371/journal.ppat.1006131.g002
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Fig 3. Phenotypes associated with loss of Ypd1 are dependent on Hog1 and Ssk1. (A) Repression or deletion of YPD1 triggers
flocculation and a swollen pseudohyphal filamentous phenotype. Micrographs of Wt, ypd1Δ, and tetO-YPD1 cells plus or minus doxycycline
(DOX) grown overnight in rich media. Images of culture tubes demonstrate the rapid sedimentation rate of cells lacking YPD1. (B)
Repression or deletion of YPD1 results in pleiotropic stress phenotypes. 104 cells, and 10-fold dilutions thereof, of exponentially growing
tetO-YPD1 cells, or wild-type (Wt), ypd1Δ and ypd1Δ+YPD1 cells, were spotted onto rich media plates (plus or minus DOX for tetO-YPD1
cells) containing NaCl (1.0 M), calcofluor white (CFW, 30 μg/ml), NaAsO2 (1.5 mM) and t-BOOH (2 mM), and incubated at 30˚C for 24h. (C)
The morphological defects exhibited by ypd1Δ cells are dependent on Hog1 and Ssk1. Micrographs of wild-type (Wt), ypd1Δ, hog1Δ (JC50),
ssk1Δ (JC1552), hog1Δ ypd1Δ (JC1475) hog1Δypd1Δ+HOG1 (JC1478), ssk1Δ ypd1Δ (JC1683), and ssk1Δ ypd1Δ+SSK1 (JC1704) cells.
(D) The high glycerol levels in ypd1Δ cells are dependent on Hog1. The mean ± SD is shown for 3 biological replicates. (E) The stress
phenotypes exhibited by ypd1Δ cells are dependent on Hog1 and Ssk1. Exponentially growing strains were spotted onto rich media plates
containing the additives detailed in B above, and incubated at 30˚C for 24h. (F) The sustained Hog1 activation in ypd1Δ cells is dependent
on Ssk1. Western blots depicting basal levels of Hog1 phosphorylation in the indicated strains. Blots were probed for phosphorylated Hog1
(Hog1-P), stripped and reprobed for total Hog1 (Hog1).
doi:10.1371/journal.ppat.1006131.g003
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or SSK1 (Fig 3C). In fact, the hog1Δ ypd1Δ double mutant cells instead displayed the morpho-
logical defects characteristic of hog1Δ cells (Fig 3C). The high glycerol levels characteristic of
ypd1Δ cells were dependent on Hog1 (Fig 3D), and the stress-phenotypes associated with dele-
tion of YPD1 were not maintained in hog1Δ ypd1Δ or ssk1Δ ypd1Δ double mutant cells (Fig
3E). Indeed, in all the conditions examined, cells lacking HOG1 and YPD1 displayed similar
stress phenotypes as hog1Δ cells, and ssk1Δ ypd1Δ cells were phenotypically similar to ssk1Δ
cells. Importantly, confirming the link between Ypd1 and Hog1 activity, reintegration of
HOG1 or SSK1 into the hog1Δ ypd1Δ and ssk1Δ ypd1Δmutants, respectively, resulted in cells
that were phenotypically identical to the ypd1Δ strain (Fig 3C and 3E). Furthermore, the
hyper-phosphorylation of Hog1 detected in ypd1Δ cells was absent in ssk1Δ ypd1Δ cells, but
was restored upon reintegration of SSK1 (Fig 3F). This result confirms that Ssk1 is essential for
the high basal level of Hog1 phosphorylation in ypd1Δ cells. Taken together, these results are
consistent with the model that accumulation of unphosphorylated Ssk1 triggers the ypd1Δ-
dependent sustained activation of Hog1 in C. albicans and, moreover, that this activation
underlies the morphological and stress phenotypes associated with loss of Ypd1.
C. albicans survives sustained activation of Hog1 by induction of the
negative regulators Ptp2 and Ptp3
We next investigated the molecular mechanism underlying the ability of C. albicans to survive
sustained Hog1 activation. In S. cerevisiae, the lethality associated with YPD1 loss can be by-
passed by the artificial over-expression of either of the protein tyrosine phosphatases, Ptp2 or
Ptp3, which normally dephosphorylate and negatively regulate Hog1 activity [31, 32]. Indeed,
YPD1 (tyrosine phosphatase dependent) was initially identified in a synthetic lethal screen for
S. cerevisiae mutants whose growth was dependent on the expression of PTP2 [33]. Similarly,
Ptp2 in C. neoformans [34] and Ptp2 and Ptp3 in C. albicans [35], have been reported to nega-
tively regulate the respective Hog1 SAPK pathways in these pathogenic fungi. Hence, it was
possible that the ability of C. albicans ypd1Δ cells to retain viability was linked to the activity of
the Ptp2 and Ptp3 phosphatases. Strikingly, we found that the expression of PTP3 is signifi-
cantly induced in ypd1Δ cells compared to wild-type cells, and PTP2 is also up-regulated albeit
to a lesser extent (Fig 4A). Similar findings were also observed upon doxycycline-mediated
repression of YPD1 in tetO-YPD1 cells (Fig 4B and 4C). Significant induction of PTP3 occurred
with similar kinetics as the increase in Hog1 activation, and some induction of PTP2 was also
evident (Fig 4B and 4C). Previous studies revealed that arsenite is a potent inhibitor of protein
tyrosine phosphatases that regulate SAPK pathways in both yeast and humans [36–38]. Inter-
estingly, C. albicans cells lacking Ypd1 are acutely sensitive to arsenite (Fig 3B), raising the pos-
sibility that arsenite-mediated inhibition of Ptp2 and/or Ptp3 causes catastrophic levels of
Hog1 phosphorylation and ultimately cell death. Indeed, in agreement with this hypothesis,
sodium arsenite treatment massively increased Hog1 phosphorylation in ypd1Δ but not wild-
type cells (Fig 4D). To confirm that arsenite primarily activates Hog1 through phosphatase
inhibition, we next examined Hog1 phosphorylation in cells expressing a mutant version of
the MAPKK Pbs2 (Pbs2DD), where the activating phosphorylation sites of Pbs2 are mutated to
phosphomimetic aspartate residues. The Pbs2DD mutant protein yields basal activation of
Hog1 but prevents further upstream signalling events to the SAPK [10]. Consistent with arse-
nite-dependent inhibition of Hog1-specific phosphatase(s), significant induction of Hog1
phosphorylation was observed in Pbs2DD cells following arsenite treatment (Fig 4E). Further-
more, this arsenite-induction of Hog1 requires Pbs2 activity as arsenite-induced Hog1 phos-
phorylation does not occur in cells expressing an inactive Pbs2AA kinase where the activating
phosphorylation sites of Pbs2 are mutated to alanine residues mimicking
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Fig 4. C. albicans cells adapt to loss of Ypd1 function by inducing negative regulators of Hog1. (A) PTP2 and PTP3 are
induced in ypd1Δ cells. Northern blot analysis of PTP2 and PTP3 expression in exponentially growing Wt (JC21 and ypd1Δ
(JC2001) cells. ACT1 was used as a loading control. (B) The kinetics of PTP3 and PTP2 are similar to that of Hog1 activation
following doxycycline treatment of tetO-YPD1 cells. Northern blot analyses of PTP2 and PTP3 expression, and western blot
analysis of Hog1 phosphorylation in tetO-YPD1 cells (JC1586) following treatment with doxycycline for the indicated times. (C)
Quantification of PTP3 and PTP2 induction following doxycycline treatment of tetO-YPD1 cells. (D) The tyrosine phosphatase
inhibitor, arsenite, further activates Hog1 in ypd1Δ cells. Western blot analysis of whole cell extracts isolated from exponentially
growing Wt and ypd1Δ cells treated with 5mM NaAsO2 for the specified times. Duplicate blots were probed for phosphorylated
Hog1 (Hog1-P) or total Hog1 (Hog1) levels. A darker exposure of the Hog1-P blot is included (middle panel) to show the level of
Hog1-P observed in Wt cells following arsenite treatment. (E) Hog1 is activated by arsenite in PBS2DD cells. Western blot analysis
of whole cell extracts isolated from exponentially growing PBS2 (JC112), PBS2AA (JC126) and PBS2DD (JC124) cells after
treatment with 5mM NaAsO2 for the specified times. Blots were probed for phosphorylated Hog1 (Hog1-P), stripped, and
reprobed for total Hog1 (Hog1) levels. (F) Deletion of PTP genes trigger greater activation of Hog1 following repression of YPD1.
Western blot analysis of whole cell extracts isolated from tetO-YPD1, tetO-YPD1 ptp3Δ (JC2188) and tetO-YPD1 ptp3ΔPTP2/
ptp2 (JC2195) cells following treatment with doxycycline for the indicated times. Duplicate blots were probed for phosphorylated
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hypophosphorylation (Fig 4E, compare PBS2 and PBS2DD with the PBS2AA lanes). Thus, these
results strongly suggest that the ability of C. albicans cells to survive sustained activation of
Hog1 upon loss of Ypd1 function is due to the action of Ptp phosphatases that reduce the levels
of phosphorylated Hog1.
To test this directly, we sought to delete both PTP2 and PTP3 in tetO-YPD1 cells with the
prediction that doxycycline-mediated repression of YPD1 in this background would result in
catastrophic levels of Hog1 activation and cell death. Initially we focused on deleting PTP3 as
this gene shows the greatest induction upon loss of YPD1 (Fig 4A and 4B). Deletion of PTP3 in
tetO-YPD1 cells resulted in notably higher levels of Hog1 phosphorylation upon repression of
YPD1 expression (Fig 4F). Moreover, deletion of PTP3 had a dramatic impact on the growth
of tetO-YPD1 cells upon doxycycline-mediated repression of YPD1, but not in the absence of
doxycycline (Fig 4G). These results support the model that induction of PTP3 promotes C.
albicans survival following Ypd1 loss by limiting Hog1 phosphorylation. However, repression
of YPD1 in ptp3Δ cells did not result in a lethal phenotype which is consistent with previous
findings that Ptp2 and Ptp3 function redundantly to regulate C. albicans Hog1 [35]. Upon
attempting to generate tetO-YPD1 ptp3Δ ptp2Δ cells we found that only one copy of PTP2
could be deleted. This was unexpected as a ptp2Δ ptp3Δ double mutant has previously been
characterised [35]. Strikingly, however, tetO-YPD1 ptp3Δ ptp2/PTP2 cells exhibited a much
higher basal level of Hog1 activation than that seen cells lacking PTP3 (Fig 4F). Following
doxycycline-mediated repression of YPD1 in ptp3Δ ptp2/PTP2 cells, further substantial
increases in Hog1 phosphorylation were detected compared to that observed in tetO-YPD1
ptp3Δ cells (Fig 4F). Indeed, consistent with the additive effect of deleting one copy of PTP2,
the growth of tetO-YPD1 ptp3Δ ptp2/PTP2 cells was barely detectable upon repression of YPD1
expression (Fig 4G). However, it is important to note that such cells also display a slow growth
phenotype under −DOX conditions when YPD1 is expressed (Fig 4G). Nonetheless, taken
together, these data support the model that the induction of PTP3 and PTP2, together with the
basal expression of PTP2, facilitate C. albicans survival following loss of the Ypd1 phosphorelay
protein.
C. albicans cells lacking Ypd1 adapt to become phenotypically similar to
wild-type cells
Although C. albicans can clearly tolerate sustained Hog1 activation, cells lacking YPD1 display
reduced fitness compared to wild-type cells (Fig 2C). Strikingly, however, we noted that ypd1Δ
cells, when maintained on rich media plates, lost the morphological abnormalities associated
with inactivation of Ypd1 function. Specifically, the swollen pseudohyphal morphology
observed in freshly isolated ypd1Δ cells (Day 1), was largely replaced with normal budding
cells after incubation on rich media plates for 13 days (Fig 5A). Because of these findings we
examined whether the stress phenotypes associated with YPD1 loss also changed over time. In
agreement with our previous findings (Fig 3), freshly isolated ypd1Δ cells (Day 1) exhibited a
slow growth rate (indicated by small colony size), and increased sensitivity to sodium arsenite
and calcofluor white. However, by day 13 the slow growth phenotype was lost, and the sensitiv-
ity to sodium arsenite and calcofluor white mimicked that exhibited by wild-type cells (Fig
5B). Consistent with this loss of morphological and stress sensitive phenotypes, we found that
the high basal level of Hog1 phosphorylation, triggered by loss of YPD1, decreased over a 13
Hog1 (Hog1-P) or total Hog1 (Hog1) levels. (G) Deletion of PTP genes impairs cell growth following repression of YPD1. 104 cells,
and 10-fold dilutions thereof, of the indicated strains were spotted onto rich media plates plus or minus DOX, and incubated at
30˚C for 24h.
doi:10.1371/journal.ppat.1006131.g004
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day period (Fig 5C). Hog1 phosphorylation levels were significantly reduced by day 10, and by
day 13 levels were similar to that seen in wild-type cells. Consistent with a reduction in Hog1
activation, the high basal level of expression of the Hog1 target gene, GPD2, also declined over
time (Fig 5D). The decrease in Hog1 phosphorylation was not due to a reduction in Hog1 pro-
tein and/or HOG1mRNA levels which remained constant over the 13 day experiment (Fig 5C
and 5D). This suggests that the sustained SAPK phosphorylation caused by loss of Ypd1 trig-
gers adaptation within the cell that results in lower levels of activated Hog1.
As we had found the negative regulators PTP3 and PTP2 to be induced in ypd1Δ cells, we
asked whether a further induction in their expression could contribute to the adaptation
mechanism resulting in the time-dependent decline in Hog1 phosphorylation levels. In agree-
ment with our previous findings (Fig 4A), we found PTP3 and PTP2 to be up-regulated in
ypd1Δ cells at day 1 and this was maintained at day 7 (Fig 5B). However, by day 10 the levels of
PTP3 and PTP2 in ypd1Δ cells had returned to wild-type levels. Hence, although C. albicans
appears to adapt to sustained SAPK activation in the short term by triggering the up-regulation
of PTP2 and PTP3, this up-regulation is temporary. Indeed, the induction of PTP2 and PTP3 is
Fig 5. C. albicans adapts to long term Ypd1 loss by lowering Hog1 activity. (A) ypd1Δ cells become morphologically similar to wild-type
cells over time. Micrographs of exponentially growing Wt (JC21) and ypd1Δ (JC2001) cells taken from rich media plates after 1 or 13 days.
(B) ypd1Δ cells gradually accumulate stress phenotypes characteristic of wild-type cells. Approximately 104 cells, and 10-fold dilutions
thereof, of exponentially growing Wt, hog1Δ (JC50) and ypd1Δ cells taken from rich media plates after 1 or 13 days were spotted onto plates
containing; NaAsO2 (1.5 mM), calcofluor white (CFW 30 μg/ml) and NaCl (0.5 M). Plates were incubated at 30˚C for 24 hrs. (C) Hog1
phosphorylation is not sustained in ypd1Δ cells over time. Western blot analysis of whole cell extracts isolated from exponentially growing Wt
and ypd1Δ cells taken from rich media plates after the number of days indicated. Blots were probed for phosphorylated Hog1 (Hog1-P),
stripped and reprobed for total Hog1 (Hog1). (D) PTP2, PTP3, and GPD2 expression is not sustained in ypd1Δ cells. Northern blot analysis
of the indicated genes in exponentially growing Wt and ypd1Δ cells taken from plates after the number of days indicated. ACT1 was used as
a loading control.
doi:10.1371/journal.ppat.1006131.g005
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only observed in cells in which significant levels of Hog1 activation are seen (compare Fig 5C
and 5D). This suggests that C. albicans adapts to Hog1 activation in the long term by via
another mechanism(s) independent of Ptp2 and Ptp3. Although the specific adaptation mech-
anism has not been identified, these results illustrate that C. albicans cells adapt to YPD1 loss
over time by reducing the levels of phosphorylated Hog1 such that the negative effects of sus-
tained SAPK activation are ablated, and ypd1Δ cells become phenotypically similar to wild-
type cells.
The reduction in Hog1 phosphorylation levels triggered by sustained
SAPK activation can be reversed following stress exposure
We asked whether the reduction in Hog1 phosphorylation levels following long-term sus-
tained Hog1 activation was irreversible. Cells lacking ypd1Δ that had been maintained for 11
days on solid rich media, were then either kept on this media (13 day) or patched onto fresh
media in the absence (-NaCl) or presence (+NaCl) of 0.3M NaCl, a stress condition known to
transiently activate Hog1 (Fig 6A). Cells were taken from these plates after 2 days, sub-cultured
in liquid media, and phosphorylation and total levels of Hog1 examined (Fig 6A). As expected,
a high basal level of Hog1 phosphorylation was absent in ypd1Δ cells at 13 days (Fig 6B). How-
ever, passage of ypd1Δ cells over plates containing NaCl, but not lacking NaCl, resulted in a
restoration of Hog1 phosphorylation (Fig 6B). To determine whether NaCl treatment could
fully restore Hog1 activation in ypd1Δ cells, we compared the level of Hog1 phosphorylation in
ypd1Δ cells over the 13 day time course with that seen following passage over NaCl plates.
Whilst exposure of ypd1Δ cells to NaCl does restore a high basal level of Hog1 phosphoryla-
tion, this is not to the same level as that seen in day 1 samples (Fig 6C). Therefore, these data
reveal that a transient exposure of ypd1Δ cells to osmotic stress can partially over-ride the
adaptation mechanism(s) that prevents sustained Hog1 phosphorylation. Wild-type cells did
not exhibit an increase in Hog1 phosphorylation after passage over media containing NaCl,
illustrating that the phosphorylation observed in ypd1Δ cells is due to a re-establishment of
sustained Hog1 activation, rather than stress-induced activation of the SAPK (Fig 6B). Fur-
thermore, the restoration of sustained Hog1 phosphorylation in ypd1Δ cells, resulted in the
return of a swollen pseudohyphal morphology (Fig 6D). Collectively, the results indicate that
the cellular adaptation mechanisms that reduce Hog1 activation in cells lacking YPD1 can be
partially over-ridden in the presence of stress that requires Hog1 function.
Repression of YPD1 expression during infection potentiates C. albicans
virulence
The lethality associated with the deletion of YPD1 in S. cerevisiae and the fungal pathogen C.
neoformans [20, 21], has led to much interest in this phosphorelay protein family as a potential
prime antifungal target [22]. Hence, we next examined the impact of doxycycline-mediated
repression of YPD1 on C. albicans virulence. The doxycycline-regulatable gene expression sys-
tem has been successfully used to control C. albicans gene expression during infection in both
a mouse model of systemic candidiasis [27, 39], and in a Caenorhabditis elegans infection
model [40]. Furthermore, repression of YPD1 expression after infection has three clear advan-
tages over testing the virulence of ypd1Δ cells directly. Firstly, this avoids the problems of accu-
rately obtaining an inoculum size with the highly flocculent and filamentous ypd1Δ strain.
Secondly, complications arising from lack of efficient dissemination of a highly flocculent
strain are circumvented. Finally, doxycycline-mediated repression of YPD1 following infection
more closely mimics the drug-induced inactivation of a particular fungal target following
infection.
Loss of Ypd1 enhances Candida albicans virulence
PLOS Pathogens | DOI:10.1371/journal.ppat.1006131 January 30, 2017 11 / 27
Initially we employed the C. albicans-C. elegans liquid medium pathogenesis assay [40] to
examine the impact of YPD1 repression on virulence. Worms were infected with tetO-YPD1 C.
albicans cells which had been grown in the absence of doxycycline and thus expressing YPD1
(Fig 2B). Subsequently, the animals were transferred to liquid medium in the presence
Fig 6. The reduction of Hog1 phosphorylation following loss of Ypd1 function can be reversed by
stress exposure. (A) Experimental overview. Freshly isolated cells were incubated on rich solid media for 11
days (depicted in grey) and then either re-streaked onto fresh rich media with (+NaCl) or without (-NaCl) 0.3M
NaCl (depicted in white) and incubated for a further 2 days, or maintained on the original plate for a further 2
days (13 day). Cells were then cultured overnight in liquid rich media lacking NaCl, and Hog1 phosphorylation
and cellular morphology examined. (B) Western blot analysis of both phosphorylated and total Hog1 levels in
Wt (JC21) and ypd1Δ (JC2001) cells treated as described in A. (C) Western blot analysis of whole cell
extracts isolated from exponentially-growing ypd1Δ cells taken either from rich media plates after the number
of days indicated, or after being re-streaked on rich media with NaCl (+NaCl) as described in A. Duplicate
blots were probed for phosphorylated Hog1 (Hog1-P) or total Hog1 (Hog1) levels. (D) Micrographs of
exponentially-growing Wt and ypd1Δ strains treated as described in A.
doi:10.1371/journal.ppat.1006131.g006
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(+DOX) or absence (-DOX) of doxycycline. Strikingly, we observed a significant increase in C.
elegans killing after infection with tetO-YPD1 cells in the presence of doxycycline in which
YPD1 expression is repressed (Fig 7A). A total of 41% of infected animals died after 72 h in liq-
uid medium containing doxycycline compared to 11% mortality in media lacking doxycycline
(P<0.001). Importantly, consistent with previous reports [40], doxycycline did not affect the
pathogenicity of wild-type C. albicans strains towards C. elegans (S2 Fig). Hence, taken
together, these results suggest that doxycycline-mediated repression of YPD1 expression actu-
ally enhances the virulence of C. albicans towards C. elegans.
To investigate whether these results could be corroborated in a distinct infection model, we
employed the three day murine intravenous challenge model of C. albicans infection [41, 42].
This model combines weight loss and kidney fungal burden measurements following 3 days of
infection to give an ‘outcome score’. A higher outcome score is indicative of greater weight
loss and higher fungal burdens and thus increased virulence. Twelve mice were infected intra-
venously with tetO-YPD1 cells grown in medium lacking doxycycline. Following infection,
one group of mice (n = 6) were orally dosed with doxycycline daily (+DOX) to repress YPD1
expression, and the second group of placebo treated mice (n = 6) given water (-DOX). Signifi-
cantly, inhibition of YPD1 expression during infection resulted in greater weight loss,
increased kidney fungal burdens, and thus higher outcome scores compared to cells which
continue to express YPD1 (Fig 7B). Consistent with previous studies [27, 39], doxycycline
treatment alone does not impact on C. albicans virulence in this mouse model of systemic can-
didiasis (S3 Fig). Histological analysis of the kidneys revealed that there was significant inflam-
mation associated with infection in the doxycycline treated animals (Fig 7C panel i), with little
inflammation seen for the placebo treated animals (Fig 7C panel iv). Clusters of filamentous
fungal cells were obvious in the doxycycline-treated mouse kidneys (Fig 7C panels ii & iii),
whereas only isolated fungal cells were found in the placebo treated kidneys (Fig 7C panels v &
vi). This indicates that the CFU measurements underestimate the increased fungal burden fol-
lowing repression of YPD1 expression, presumably as a consequence of the increased filamen-
tation. Nonetheless statistical analysis revealed that the difference between +DOX and −DOX
cells was significant for all three parameters, including fungal burden (Fig 7B). Collectively,
these studies illustrate that repression of YPD1 expression during infection in two distinct ani-
mal models enhances the virulence of C. albicans. These results have clinical significance as
they predict that a drug designed to block two-component signalling in C. albicans could actu-
ally promote the virulence of this major human fungal pathogen.
To further investigate how Ypd1 loss promotes C. albicans virulence, we employed live cell
video microscopy to follow the impact of inhibition of YPD1 expression on C. albicans-macro-
phage interactions. Specifically, tetO-YPD1 cells were treated with (+DOX) or without (-DOX)
doxycycline for 3 h prior to co-incubation with murine J774.1 macrophages, which were then
grown in media +/-DOX, respectively. Quantitatively, there were no significant differences
between the migration speed of J774.1 macrophages towards tetO-YPD1 cells treated or not
with doxycycline, or rate of engulfment of fungal cells (S4 Fig). Importantly, however, doxycy-
cline mediated-repression of YPD1 resulted in C. albicans cells that displayed a significantly
enhanced ability to kill macrophages. It was observed that 82±4.1% of macrophages were killed
following co-incubation with tetO-YPD1 cells in the presence of doxycycline (+DOX), com-
pared to 60±3.0% macrophages killed in the absence of doxycycline (-DOX) (P<0.01) (Fig
7D). The ability of C. albicans to transition to the hyphal form following phagocytosis is pivotal
in triggering macrophage death [43]. Thus, the rate of hyphae formation of tetO-YPD1 cells
following phagocytosis by macrophages was measured. Hyphal growth was significantly faster
in tetO-YPD1 cells grown in the presence of doxycycline (0.35±0.032 μm/min) than in the
absence of doxycycline (0.26 ± 0.023 μm/min) (Fig 7E). These results illustrate that repression
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Fig 7. Repression of YPD1 expression during infection potentiates C. albicans virulence. (A) C. elegans model of infection.
Nematodes were infected with the conditional tetO-YPD1 strain (JC1586) and transferred to liquid medium either with (+DOX) or without
(-DOX) doxycycline. Doxycycline treatment consistently increased the rate of killing of the nematodes infected with the tetO-YPD1 strain
(P<0.001). These data are from a single experiment representative of three independent biological replicates. (B) Mouse model of infection.
Kidney fungal burden measurements, percentage weight loss, and outcome score measurements of mice infected with tetO-YPD1 cells and
administered doxycycline (+DOX) or not (-DOX). Comparison of +DOX and -DOX treated groups by Kruskal-Wallis statistical analysis
demonstrates significant differences for all three parameters with doxycycline treated mice giving a significantly greater outcome score
(*P<0.05, **P<0.01). (C) Increased virulence of cells with repressed YPD1 expression is associated with increased numbers of fungi and
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of YPD1 expression promotes hyphal growth following phagocytosis which in turn likely
enhances the ability of C. albicans to kill macrophages. Given the importance of macrophages
in immune responses to C. albicans infections, the increased capacity of C. albicans cells lack-
ing Ypd1 to kill macrophages likely contributes to the enhanced virulence observed in a
murine model of systemic infection.
Discussion
The generation of fungal pathogen-specific drugs is hindered by the conservation of many
potential drug-targets in the human host. Thus the complete absence of two-component
related proteins in metazoans, but their presence in fungi, has rendered such pathways attrac-
tive drug-targets [22, 44, 45]. In S. cerevisiae, and the human fungal pathogen C. neoformans,
loss of the two-component phosphorelay protein Ypd1 causes lethality due to the sustained
activation of their respective SAPK pathways [20, 21]. However, as reported during the course
of this work [25], a major human fungal pathogen, C. albicans, can tolerate sustained activation
of the Hog1 SAPK pathway triggered by loss of Ypd1. We have significantly advanced our
understanding of this observation in three main ways. Firstly we find that the constitutive acti-
vation of Hog1 in cells lacking YPD1 is mediated through two-component mediated regulation
of the Ssk1 response regulator, and that the pleiotropic phenotypes associated with Ypd1 loss
are dependent on Ssk1-mediated Hog1 activation. Secondly, we have provided novel insight
into the mechanisms by which C. albicans survives and adapts to sustained SAPK activation.
Thirdly, we show that inactivation of YPD1 promotes, rather than reduces, the virulence of C.
albicans, and we provide evidence to suggest that this is mediated at least in part through
effects on fungus-phagocyte interactions. A model summarising the major findings from this
work is depicted in Fig 8.
One question raised by this study is why is sustained SAPK activation tolerated in some
fungi but not others? In S. cerevisiae, prolonged SAPK activation is reported to lead to cell
death by causing an increase in reactive oxygen species (ROS) thus triggering apoptosis [12].
Although we do not know whether sustained Hog1 activation triggers an increase in intracel-
lular ROS in C. albicans, it is worth noting that C. albicans is considerably more resistant to
oxidative stress than S. cerevisiae [46]. In C. neoformans, lethality due to Hog1 hyperactivation
is attributed to the over-accumulation of intracellular glycerol [47]. In C. albicans, sustained
Hog1 activation in ypd1Δ cells also triggers an increase in intracellular glycerol levels, presum-
ably contributing to the associated swollen cell phenotype. Interestingly, this is tolerated in
these mutant cells and indeed it is noteworthy that C. albicans can withstand higher levels of
osmotic stress (which triggers glycerol biosynthesis) than many other fungal species [46].
However, perhaps a key factor in maintaining the viability of ypd1Δ cells, is the significant
induction of the tyrosine phosphatase encoding genes PTP2 and PTP3 which negatively regu-
late Hog1 phosphorylation [35]. Interestingly, the lethality associated with ypd1Δ-mediated
inflammation in the infected kidneys. Representative images from kidneys of mice infected with tetO-YPD1 cells and treated with (+DOX; i-
iii) or without (-DOX; iv-vi) doxycycline. Sections (5 μm) were Periodic Acid-Schiff stained and post-stained with Hematoxylin. Low
magnification images in (i) and (iv) (scale bar = 200 μm) show the difference in lesion number and extent of inflammatory response. Higher
magnification (scale bar = 50μm) shows the presence of clusters of filamentous fungal cells (white arrows) in the lesions of doxycycline-
treated mouse kidneys (ii & iii) and isolated single pseudohyphal fungal cells (white arrows) in placebo-treated mouse kidneys (v & vi). (D)
Macrophage model of infection. C. albicans mediated killing of macrophages was determined by detecting the number of ruptured
macrophages following co-culture with or without tetO-YPD1 cells in the presence (+DOX) or absence (-DOX) of doxycycline. ANOVA was
used to determine statistical significance (** P 0.01). (E) Assessment of hyphal growth following phagocytosis by tetO-YPD1 cells in the
presence (+DOX) or absence (-DOX) of doxycycline. The left panel shows that +DOX treatment resulted in a faster rate of hyphal growth.
ANOVA was used to determine statistical significance (** P 0.01). The right panel shows images taken 61 mins post engulfment of yeast
cells. The scale bar is 9 μm, and the white arrows indicate hyphal cells within the macrophage.
doi:10.1371/journal.ppat.1006131.g007
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sustained Hog1 activation in S. cerevisiae can be by-passed by artificial over-expression of
either PTP2 or PTP3 [31, 32], suggesting that C. albicans actually adopts this strategy to prevent
catastrophic levels of Hog1 activation. Consistent with this hypothesis is the observation that
treatment of C. albicans ypd1Δ cells with the tyrosine phosphatase inhibitor, arsenite, triggers a
significant increase in levels of Hog1 phosphorylation and cell death. Furthermore, deletion of
PTP3 together with deletion of one copy of PTP2, triggers dramatic increases in the level of
phosphorylated Hog1 in tetO-YPD1 cells and furthermore, virtually abolishes cell growth fol-
lowing doxycycline-mediated repression of YPD1. It is not clear why we could not generate
tetO-YPD1 cells lacking both PTP3 and PTP2, as a double ptp3Δ ptp2Δmutant has previously
been characterised [35], although it is possible that basal YPD1 expression levels are altered in
the tetO-YPD1 background. Notably, however, we find that the basal level of expression of
PTP2 plays a major role in preventing Hog1 activation under non-stress conditions, as signifi-
cant increases in the levels of Hog1 phosphorylation are seen upon deleting one copy of PTP2.
Similar findings have been reported in both S. cerevisiae and C. neoformans where basal levels
Fig 8. Ypd1 inactivation in C. albicans triggers Hog1 hyperactivation, increased virulence, and in the
long term a reduction in Hog1 activity. Model depicting outcomes following YPD1 loss in C. albicans. Loss
of Ypd1 results in the accumulation of the unphosphorylated Ssk1 response regulator, which drives the
activation of Hog1 under non-stressed conditions. The levels of Hog1 phosphorylation are modulated by the
induction of the negative regulators Ptp2 and Ptp3 which allows cells to adapt and survive Ypd1 loss. Loss of
Ypd1 function during infection increases the virulence of C. albicans, by possibly enhancing Hog1 activity
promoting stress resistance and/or filamentation. Furthermore, C. albicans adapts to long-term activation of
Hog1 by reducing the levels of the phosphorylated Hog1 kinase. This adaptation process prevents
phenotypes associated with sustained SAPK activation and ypd1Δ cells now phenotypically resemble wild-
type cells. Notably, however, this adaptation mechanism to circumvent Hog1 phosphorylation can be over-
ridden following transient stress exposure and thus sustained Hog1 activation is restored.
doi:10.1371/journal.ppat.1006131.g008
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of Hog1 are significantly increased in ptp2Δmutant cells [31, 34]. Taken together, the data pre-
sented in this paper strongly support the model that induction of PTP3 and PTP2 expression,
together with the basal expression of PTP2, allow C. albicans to survive loss of the Ypd1 phos-
phorelay protein.
The viability of C. albicans cells lacking Ypd1 has allowed an investigation of how fungal
cells adapt to long-term sustained SAPK activation. Remarkably, we find that cells evoke a
mechanism that prevents the long-term constitutive phosphorylation of Hog1. Moreover, this
decrease in Hog1 phosphorylation is actually accompanied by a reduction in the levels of PTP2
and PTP3, the negative regulators of Hog1, raising the possibility that an upstream signalling
branch to Hog1 is inhibited instead. Furthermore, this mechanism is reversible as it can be
over-ridden following a transient exposure to stress that requires Hog1 activity. Do these
observations that C. albicans can survive and adapt to sustained SAPK activation have physio-
logical relevance? As a human commensal, this fungal pathogen is continuously exposed to
host-imposed stresses. Indeed, Hog1 is vital for C. albicans to exist commensally in the gut
[11], cause systemic infections [8, 10], and survive phagocytosis [9]. Thus, the ability of this
pathogen to adapt to sustained SAPK activation by actively modulating Hog1 phosphorylation
levels may be important to promote survival in certain host niches that continuously generate
a stressful environment. Furthermore, we propose that the capacity of C. albicans to restore
levels of SAPK phosphorylation, upon subsequent exposure to conditions that require Hog1-
mediated stress responses, underpins the flexibility needed to allow adaptation of C. albicans
to the range of environments encountered within the host [48]. Interestingly, long-term SAPK
activation can be tolerated in other organisms. For example, in some human cell types sus-
tained SAPK activation promotes either cell survival [49] or cellular differentiation [50], rather
than apoptosis. However, whether similar mechanisms are evoked in humans and C. albicans,
to adapt to sustained SAPK activation is unknown.
The main findings reported here in this paper focused on cells in which HOG1 is expressed
from its native chromosomal locus. However, during the course of this work we noted that the
cellular response of C. albicans to YPD1 loss differed depending on whether the HOG1 gene
was present at its native locus, or re-integrated at the RPS10 locus in hog1Δ ypd1Δ+HOG1 cells.
In both instances, cells adapted to long term SAPK activation by reducing the levels of phos-
phorylated Hog1 (S5A and S5B Fig). However, when HOG1was reintegrated at the RPS10
locus, this was also accompanied by a reduction in HOG1mRNA levels (S5C Fig). Consistent
with the decrease in Hog1 levels, hog1Δ ypd1Δ+HOG1 cells changed dramatically over time to
phenocopy hog1Δ cells (S5D Fig). These results contrast significantly with those from ypd1Δ
cells when HOG1 is expressed from its normal locus where the cells change over time to phe-
nocopy wild type cells (compare Fig 5 and S5 Fig). Indeed, the ypd1Δ-dependent down-regula-
tion of HOG1 located at the RPS10 locus was independent of HOG1 promoter and terminator
sequences (S5E Fig), suggesting that this is a genome position-effect rather than a gene-specific
phenomenon. Insertion of genes at the RPS10 locus has been employed by numerous labs to
successfully generate re-integrant strains [51, 52]. Significantly, the present study has
highlighted the importance of studying a gene at its native chromosomal locus when investi-
gating the role and/or regulation of the gene.
Two-component proteins represent attractive antifungal targets as these signal transduction
proteins are absent in metazoans [22, 44, 45]. Indeed, deletion of any one of the three C. albi-
cans histidine kinases, or the Ssk1 response regulator, attenuate virulence in mouse systemic
infection models. Furthermore, the Ypd1 phosphorelay protein has generated significant inter-
est as an antifungal target, due to the lethality associated with its deletion in both S. cerevisiae
and the human fungal pathogen C. neoformans [20, 21]. However, in this study we report that
inhibition of YPD1 expression during infection actually increases the virulence of C. albicans
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in two distinct infection models; a C.elegans pathogenesis model [40] and a murine model of
systemic candidiasis [41, 42]. Histology images from murine kidneys show that, similar to that
seen in vitro, repression of YPD1 during infection results in clusters of highly filamentous cells.
Enhanced filamentation in vivo has previously been shown to increase virulence [39], and thus
the increased virulence associated with YPD1 loss in vivo may be due to the formation of clus-
ters of hyper-filamentous cells. Moreover, we show that drug mediated inhibition of YPD1
expression increases the efficacy by which C. albicans can kill macrophages. This is likely
related to the observation that Ypd1 loss also results in increased filamentation within this
infection model, as hyphae formation within the macrophage promotes C. albicans-mediated
killing of macrophages by triggering pyroptosis [53], and by mechanically rupturing the mac-
rophage cell membrane [54].
The molecular basis underlying the increased virulence seen upon repressing YPD1
expression is unknown, but given that Hog1 is essential for C. albicans virulence in several
infection models [8–11], it is possible that the concomitant increases in Hog1 activity as a
consequence of Ypd1 loss promotes C. albicans survival in the host (Fig 8). It is important to
note here that the filamentous phenotype exhibited by cells lacking Ypd1 is due to the con-
comitant sustained Hog1 activation. To explore whether the enhanced virulence seen upon
Ypd1 loss was dependent on Hog1, we compared the virulence of wild-type, hog1Δ and
hog1Δ ypd1ΔC. albicans cells in the three day murine infection model described above.
Although it was not feasible to analyse ypd1Δ cells in this model due to the highly flocculent
nature of this strain, hog1Δ and hog1Δ ypd1Δ cells demonstrated equally impaired virulence
in the three-day murine systemic infection model (S1 Table). Thus the impaired virulence
exhibited by hog1Δ cells is not improved upon deletion of YPD1 and, therefore, is consistent
with the hypothesis that the enhanced virulence observed upon loss of YPD1 may be depen-
dent on the concurrent increased activation of the Hog1 SAPK to promote fungal stress resis-
tance and/or filamentation.
Importantly, the data presented here illustrating that Ypd1 loss potentiates C. albicans viru-
lence, indicates that antifungals administered to treat C. albicans infections that target Ypd1
have the potential to actually enhance the virulence of this major pathogen. It is also notewor-
thy that SAPKs are important for the virulence of other human and plant fungal pathogens
[55]. Consequently, any compound capable of inhibiting two-component signalling that leads
to SAPK activation, may promote the survival of other fungal pathogens when encountering
host-imposed stresses. Thus, in conclusion, our findings question the validity of the Ypd1 pro-
tein as a broad-spectrum antifungal target. Indeed, the significant differences in stress-signal-
ling outputs between S. cerevisiae and C. albicans, underscores the importance of directly
studying predicted ‘essential’ genes in pathogenic fungi, rather than in model yeast.
Materials and methods
Strains and growth media
All the C. albicans strains used in this study are listed in Table 1. Cells were grown at 30˚C in
YPD rich medium [56]. Addition of 20μg/ml doxycycline was used to repress expression from
the tetO promoter.
Strain construction
The strains used in this study are listed in Table 1, and oligonucleotides used for their con-
struction are listed in S2 Table.
Doxycycline-mediated repression of YPD1. To place YPD1 under control of the tetO
promoter, one allele of YPD1 was disrupted in strain THE1 [27] to generate JC1420. Ura-
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blasting was used to delete one YPD1 allele [57] using a ypd1::hisG-URA3-hisG cassette gener-
ated by amplifying regions flanking the YPD1 open reading frame (ORF), using the oligonucle-
otide primer pairs Ypd1BglIIF/Ypd1BglIIR and Ypd1BamHIF/Ypd1BamHIR respectively, and
sequentially ligating into p5921. The ypd1::hisG-URA3-hisGdisruption cassette deleted the
entire 184 codon YPD1 ORF. The strain was then passed over 5FOA to recycle the URA3
marker. To place YPD1 under the tetO promoter, sequences containing nucleotides −382 to
−71 (sequence A) and −8 to +294 (sequence B) relative to the start codon of YPD1 were PCR
amplified using the primer pairs YPD1KPNIA.F/YPD1CLAIA.R and YPD1SACIIB.F/YPD1-
SACIIB.R respectively. The PCR products were digested with KpnI/ClaI (sequence A) and
SacII (sequence B) and sequentially ligated into the p99CAU1 plasmid [27]. The 2.8kb URA3-
TET-YPD1 construct was then released from the plasmid as a KpnI-SacII fragment and intro-
duced into JC1420 cells to generate strain tetO-YPD1 (JC1586). All gene disruptions, and cor-
rect integration of fragments, were confirmed by PCR.
Deletion of YPD1. To delete YPD1, a disruption cassette comprising of the HIS1 gene
flanked by loxP sites and 80 base pairs of DNA sequence corresponding to regions 5’ and 3’ of
the YPD1 ORF, were generated by PCR using the oligonucleotide primers YPDdelF and YPD-
delR and the plasmid template pLHL2 respectively. The disruption cassette was transformed
into C. albicans RM1000 to disrupt one allele of YPD1 and generate strain JC1338. The second
copy of YPD1 was deleted using the ura blasting cassette as described above, to generate
JC1990. To re-introduce YPD1, the YPD1 locus was PCR amplified using the oligonucleotide
primers Ypd1PromF and Ypd1TermR and cloned into the integrating plasmid CIp20 [51].
Table 1. Strains used in this study.
Strain Relevant Genotype Source
THE1 ade2::hisG/ade2::hisG, ura3::imm434/ura3::imm434, ENO1/eno1::ENO1-tetR-ScHAP4AD-3×HA-ADE2 [27]
JC1586 THE1 ypd1::hisG/ypd1::99t-YPD1-URA3 This study
JC2188 THE1 ypd1::hisG/ypd1::99t-YPD1-URA3, ptp3::loxP/ptp3::loxP This study
JC2195 THE1 ypd1::hisG/ypd1::99t-YPD1-URA3, ptp3::loxP/ptp3::loxP PTP2/ptp2::loxP This study
RM1000 ura3:: imm434/ura3::imm434, his1::hisG/his1::hisG [62]
JC21 RM1000 + CIp20 [6]
JC50 RM1000 hog1::loxP-ura3-loxP, hog1::loxP-HIS1-loxP + CIp20 [6]
JC52 RM1000 hog1::loxP-ura3-loxP, hog1::loxP-HIS1-loxP + CIp20-HOG1 [6]
JC1475 RM1000 hog1::loxP-ura3-loxP, hog1::loxP-HIS1-loxP, ypd1::hisG/ypd1::hisG + CIp20 This study
JC1478 RM1000 hog1::loxP-ura3-loxP, hog1::loxP-HIS1-loxP, ypd1::hisG/ ypd1::hisG + CIp20-HOG1 This study
JC1850 RM1000 hog1::loxP-ura3-loxP, hog1::loxP-HIS1-loxP pACT-HOG1 This study
JC1851 RM1000 hog1::loxP-ura3-loxP, hog1::loxP-HIS1-loxP, ypd1::hisG/ypd1::hisG pACT1-HOG1 This study
JC1859 RM1000 hog1::loxP-ura3-loxP, hog1::loxP-HIS1-loxP, ypd1::hisG/ypd1::hisG CIp20-HOG1 This study
JC1860 RM1000 hog1::loxP-ura3-loxP, hog1::loxP-HIS1-loxP, ypd1::hisG/ypd1::hisG CIp20-HOG1 This study
JC1990 RM1000 ypd1::HIS1/ypd1::hisG-URA3-hisG This study
JC2001 RM1000 ypd1::HIS1/ypd1::hisG CIp20 This study
JC2002 RM1000 ypd1::HIS1/ypd1::hisG CIp20-YPD1 This study
SN148 arg4Δ/arg4Δ leu2Δ/leu2Δ his1Δ/his1Δ, ura3Δ::imm434/ ura3Δ::imm434, iro1Δ::imm434/ iro1Δ::imm434 [63]
JC1552 SN148 ssk1::loxP-ARG4 -loxP/ssk1::loxP-HIS1-loxP + CIp20 [29]
JC1683 SN148 ssk1::loxP-ARG4 -loxP/ssk1::loxP-HIS1-loxP, ypd1::hisG/ ypd1::hisG + CIp20 This study
JC1704 SN148 ssk1::loxP-ARG4 -loxP/ssk1::loxP-HIS1-loxP, ypd1::hisG/ ypd1::hisG + CIp20-SSK1 This study
JC112 BWP17 pbs2::loxP-HIS1-loxP/ PBS2-HM:URA3 [64]
JC124 BWP17 pbs2::loxP-HIS1-loxP/ PBS2DD-HM:URA3 [10]
JC126 BWP17 pbs2::loxP-HIS1-loxP/ PBS2AA-HM:URA3 [10]
doi:10.1371/journal.ppat.1006131.t001
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CIp20 and CIp20-YPD1 were integrated at the RPS10 locus in a 5-FOA resistant derivative of
JC1990 to create strains JC2001 and JC2002 respectively. Both copies of YPD1 were also
deleted in hog1Δ cells (JC47; [6]) and ssk1Δ cells (JC1402; [29]) using the ura-blaster cassette to
generate strains JC1450 (hog1Δ ypd1Δ) and JC1656 (ssk1Δ ypd1Δ), respectively. Single copies
of either HOG1 or SSK1 were reintegrated into these strains. The SSK1 gene plus 970bp of the
promoter region and 237bp of the terminator region was amplified by PCR, using the oligonu-
cleotide primers Ssk1BamHIF and Ssk1BamHIR, and ligated into the BamHI site of CIp20
[51] to generate CIp20-SSK1. CIp20-HOG1 [6] and CIp20-SSK1 were digested with StuI and
integrated at the RPS10 locus in the hog1Δ ypd1Δ and ssk1Δypd1Δ double mutants, respec-
tively, to generate strains JC1478 and JC1704. The CIp20 vector was also integrated at the
RPS10 locus in the ssk1Δ ypd1Δ and hog1Δ ypd1Δ double mutants to generate strains JC1683
and JC1475 respectively.
Deletion of PTP3 and PTP2. These mutants were constructed using the Clox system
with nourseothricin selection [52]. To create the ptp3Δmutant, the NAT1-Clox cassette was
PCR amplified using primer pairs PTP3delF and PTP3delR, and introduced into tetO-YPD1
cells to sequentially delete both PTP3 alleles and generate strain (JC2188). The same strategy
was used to delete PTP2 in JC2188 using the primer pairs PTP2delF and PTP2delR. One copy
of PTP2 was deleted generating the strain tetO-YPD1 ptp3Δ ptp2/PTP2 (JC2195). Despite
extensive efforts the second copy of PTP2 could not be deleted in JC2195.
Ectopic expression of HOG1. The HOG1 open reading frame was amplified by PCR,
using the primer pair Hog1HindIIIF and Hog1HindIIIR and CIp20-HOG1 as template, and
ligated into the HindIII site between the CaACT1 promoter and the ScCYC1 terminator in
pACT1 [58]. The resulting pACT1-HOG1 plasmid was integrated at the RPS10 locus in
hog1Δ ypd1Δ cells, and two individual transformants (JC1850, JC1851) were immediately fro-
zen at -80˚C to prevent reversion of ypd1Δ-dependent phenotypes. The CIp20-HOG1 plas-
mid [6], which contains the HOG1 ORF and promoter and terminator sequences, was
integrated at the RPS10 locus in the hog1Δ ypd1Δ cells, and two individual transformants
(JC1859, JC1860) also immediately frozen at -80˚C. Correct integration at the RPS10 locus
and the DNA sequences of the integrated open reading frames were confirmed by PCR and
DNA sequencing, respectively.
Glycerol assay
Glycerol concentrations were determined using The Free Glycerol Determination Kit (Sigma-
Aldrich), following the manufacturer’s instructions. Three independent biological replicates
were performed.
Hog1 phosphorylation assays
Protein extracts were prepared from mid-exponential phase cells and phosphorylated Hog1
was detected by western blot analysis with an anti-phospho-p38 antibody (New England Bio-
labs) as described previously [6]. Blots were stripped and total levels of Hog1 were determined
by probing with an anti-Hog1 antibody (Santa Cruz Biotechnology), and in some cases protein
loading determined using an anti-tubulin antibody (DSHB, University of Iowa).
Northern blot analysis
RNA preparation and Northern blot analyses were performed as described previously [6].
Gene-specific probes were amplified by PCR from genomic DNA using oligonucleotide prim-
ers specific for YPD1, GPD2, RHR2, PTP2, PTP3, HOG1 and ACT1 (S1 Table).
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Stress sensitivity tests
C. albicans strains were grown at 30˚C to exponential phase and then 10 fold serial dilutions
were spotted onto YPD plates containing the indicated compounds. Plates were incubated at
30˚C for 24 h.
Microscopy
Differential interference contrast images were captured using a Zeiss Axioscope microscope as
described previously [6].
Virulence analysis
C. elegans pathogenesis assay. This was performed essentially as described previously
[40]. Freshly grown C. albicans cells were inoculated into 10 ml of YPD and grown overnight
at 30˚C. The following day cells were diluted to an OD660 0.2, and 10 μl of yeast was spotted
onto a 5-cm plate containing Brain Heart Infusion BHI agar and kanamycin (45 μg/ml), and
incubated overnight at room temperature. Synchronized adult C. elegans (glp-4) nematodes
grown at 25˚C were washed from NGM-L plates containing their normal food source (E. coli
OP50) using sterile M9 buffer. Approximately 400 washed animals were then pipetted to the
centre of the C. albicans lawn and incubated at 25˚C for 4 h. Worms were then transferred to
sterile M9 medium and washed three times. At least 60 worms were then pipetted into a single
well of a six-well tissue culture plate containing 2 ml of liquid medium (80% M9, 20% BHI)
supplemented or not with doxycycline (20μg/ml). The culture plate was incubated at 25˚C,
and worm survival was scored daily under a stereomicroscope. Worms were considered to be
dead if they did not move in response to probing with a pick, and were removed from the
assay. Survival was analysed using the Kaplan-Meier method and differences in C. elegans sur-
vival were determined by the log-rank test.
Murine intravenous challenge assay. Murine BALB/c female mice (6–8 weeks old,
Envigo UK) were housed in randomly assigned groups of 6, with food and water provided
ad libitum. In the first set of experiments mice were infected intravenously via a lateral tail
vein with 4.5e4 CFU/g of C. albicans tetO-YPD1 cells grown in medium lacking doxycycline.
Treatments were randomly assigned to groups of infected mice. One group of mice (n = 6)
was gavaged (orally dosed) with 2 mg doxycycline daily (+DOX), and the second group of
placebo treated mice (n = 6) orally dosed with water (-DOX). In the second group of experi-
ments, mice (n = 6) were infected with 2.5e4 CFU/g wild-type (JC21), hog1Δ (JC50) or
hog1ypd1Δ (JC1475) cells. Body weights were recorded daily. 72 h after challenge the animals
were weighed, humanely terminated and kidneys removed aseptically. Fungal burdens were
measured by viable counts for two half kidneys per animal. Virulence was assessed by fungal
kidney burdens at 72 h, and by percent weight change over 72 h, from which an outcome
score was calculated [41, 42]. The wild-type (JC21), hog1Δ (JC50) and hog1ypd1Δ (JC1475)
cells contain a single copy of URA3 integrated at the RPS10 locus and thus the levels of URA3
expression within these strains should be identical. In addition, the tetO-YPD1 strain is
Ura3+ (Table 1), and the only difference between the two groups of mice injected with this
strain is doxycycline treatment. Hence the levels of URA3 expression in tetO-YPD1 cells in
both -DOX and +DOX groups of mice should be identical. This is important to avoid any
indirect effects on virulence due to differing levels of URA3 expression [59]. Furthermore, as
previously reported, doxycycline treatment alone does not impact on C. albicans virulence
(S3 Fig). Differences were tested by Kruskal-Wallis statistical analysis using IBM SPSS Statis-
tics v24.
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Kidney sections were prepared from formalin-fixed halves of kidneys from infected mice.
Kidney halves were embedded in paraffin wax and 5 μm sections cut. Sections were deparaffi-
nized and underwent Periodic Acid-Schiff staining, with hematoxylin post-staining. Images
were captured using a Zeiss Axioscan Z1 slide scanner.
Phagocytosis assays and live-cell video microscopy. These experiments were per-
formed as described previously [60]. The J774.1 mouse macrophage cell line (European Col-
lection of Cell Culture) was maintained at 37˚C and 5% CO2 in Dulbecco‘s modified Eagle‘s
medium (DMEM) (Lonza, Slough, UK) supplemented with 10% heat-activated fetal calf
serum (FCS) (Biosera, Ringmer, United Kingdom). Cells were seeded at a density of 1.2 x105
cells/well in an 8-well slide and incubated overnight at 37˚C and 5% CO2. Prior to co-incuba-
tion growth medium in wells was replaced with prewarmed CO2-independent medium
containing 10% FCS (Invitrogen) and supplemented or not with doxycycline (20 μg/ml).
Overnight cultures of the tetO-YPD1 strain grown in rich media lacking doxycycline (20 μg/
ml) was diluted into fresh media supplemented or not with doxycycline (20 μg/ml) and incu-
bated for 3 h, following which cells were washed in sterile phosphate-buffered saline (PBS)
(pH7.4) and co-cultured with J774.1 cells at a MOI of 3:1 respectively. DIC images of co-cul-
tured cells were taken at 1-min intervals over a 6 h time course using an Ultra VIEW VoX
spinning-disk microscope (Nikon, Surrey, United Kingdom) and an EMCCD camera. Two
independent experiments were carried out and 6 movies analysed from each experiment per
C. albicans strain. Fifty macrophages were randomly selected from each movie and phago-
cytic activity determined. Volocity 5.0 imaging software (Improvision, PerkinElmer, Coven-
try, United Kingdom) was used for data acquisition and analysis as described previously [61].
The software enabled the determination of the engulfment time, uptake events, rate of C. albi-
cans filamentation, and macrophage survival. Macrophage survival/killing was determined
by detecting the number of ruptured macrophages within sample populations of 50. Differ-
ences were tested for statistical significance by one-way analysis of variance (ANOVA) with
Bonferonni‘s post hoc comparisons.
Ethics statement
All animal experiments were conducted in compliance with United Kingdom Home Office
licenses for research on animals (project license number PPL 60/4135), and were approved
by the University of Aberdeen Animal Welfare and Ethical Review Body (AWERB).
Animal experiments were minimised, and all animal experimentation was performed
using approaches that minimised animal suffering and maximised our concordance with
the 3Rs.
Supporting information
S1 Table. Effect of deleting Hog1, or Hog1 and Ypd1, on experimental infection outcome.
Infection with either hog1Δ or hog1Δ ypd1Δ cells resulted in weight increases, lower kidney
fungal burdens and, thus, lower outcome scores compared to that observed with wild-type
cells. Statistical analysis revealed that for all parameters; weight loss, kidney fungal burden and
outcome score, the difference between each mutant strain with wild-type cells was significant
(P<0.05). However, there was no significant difference for any of the parameters between
hog1Δ and hog1Δ ypd1Δ cells.
(DOCX)
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S2 Table. Oligonucleotides used in this study.
(DOCX)
S1 Fig. Doxycycline does not stimulate Hog1 phosphorylation. The indicated strains were
treated or not with 20μg/ml doxycycline (DOX) for 1 h, and cell extracts were analysed for
phosphorylated Hog1 by western blotting. Blots were probed for phosphorylated Hog1
(Hog1-P), stripped and reprobed for total Hog1 (Hog1). Hog1 phosphorylation is stimulated
upon doxycycline-mediated reduction of YPD1 expression in tetO-YPD1 cells (JC1586), but
not in the parental THE1 and THE1 ypd1::hisG (JC1420) strains following doxycycline treat-
ment.
(TIFF)
S2 Fig. Doxycycline treatment does not affect C. albicans virulence in a C. elegans model of
infection. Nematodes were infected with wild-type THE1 or wild-type JC806 cells and trans-
ferred to liquid medium either with (+DOX) or without (-DOX) doxycycline. Doxycycline
had no significant impact on nematode killing infected with either wild-type strain in
(P>0.05). These data are from a single experiment representative of two independent biologi-
cal replicates.
(TIF)
S3 Fig. Doxycycline treatment does not affect C. albicans virulence in a murine infection
model. Kidney fungal burden measurements, percentage weight loss, and outcome score mea-
surements of mice infected with wild-type C. albicans cells (SC5314) and administered doxycy-
cline (+DOX) or not (-DOX). Comparison of +DOX and -DOX treated groups by Kruskal-
Wallis statistical analysis found no significant differences for any of the three parameters.
(TIF)
S4 Fig. Doxycycline treatment does not affect rate of uptake of C. albicans tetO-YPD1 cells.
(A) Percentage uptake of tetOYPD1 cells grown in the presence (+DOX) or absence (-DOX) of
doxycycline. No significant difference between uptake events + or − minus Dox by J774.1 mac-
rophages after 6h co incubation was detected. (B) Engulfment time required for the ingestion
of tetOYPD1 cells grown in the presence (+DOX) or absence (-DOX) of doxycycline. The bars
represent the average time (minutes) taken for the complete engulfment of the cells by J774.1
macrophages. No significant differences between the rate of engulfment of fungal cells − or +
Dox treatment were detected.
(TIF)
S5 Fig. HOG1 is regulated differently at the RPS10 locus in response to sustained Hog1
activation. (A) Hog1 phosphorylation is not sustained in hog1Δypd1Δ+HOG1cells over time
and this is accompanied by a reduction in total Hog1 protein levels. Western blot analysis of
whole cell extracts isolated from exponentially growing hog1Δ+HOG1 (JC52) and hog1Δypd1Δ
+HOG1 (JC1478) cells taken from rich media plates after the number of days indicated.
indicates a non-specific band. (B) Comparison of Hog1 phosphorylation and Hog1 levels in
hog1Δypd1Δ+HOG1and ypd1Δ (JC2001) cells. Western blots were also probed for tubulin
(Tub) in addition to phosphorylated (Hog1-P) and total Hog1 (Hog1). (C) GPD2 expression is
not sustained in hog1Δypd1Δ+HOG1cells and this correlates with a decline in HOG1mRNA
levels. Northern blot analysis of HOG1 and GPD2 expression in exponentially growing cells
taken from rich media plates after the number of days indicated. The relative expression of
HOG1 and GPD2 to the ACT1 loading control in is shown. (D) hog1Δ ypd1Δ+HOG1cells grad-
ually accumulate phenotypes characteristic of hog1Δ cells. Approximately 104 cells, and 10-fold
dilutions thereof, of exponentially growing cells taken from rich media plates after Day 1 or
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Day 9 were spotted onto plates containing; NaAsO2 (1.5 mM), calcofluor white (30 μg/ml) and
NaCl (0.5 M). Plates were incubated at 30˚C for 24 hrs. Micrographs illustrating the morphol-
ogy of hog1Δ+HOG1 and hog1Δypd1Δ+HOG1cells at Day 1 and Day 9 are also shown. (E)
Reduction of Hog1 levels at the RPS10 locus occurs independently of the HOG1 promoter
sequence. Western blot analysis of whole cell extracts isolated from two freshly isolated inde-
pendent hog1Δ ypd1Δ strains expressing HOG1 integrated at the RPS10 locus from its native
promoter (JC1859, JC1860; left panel) or the ACT1 promoter ACT1p-HOG1 (JC1850, JC1851;
right panel). Blots were processed as described in B.
(TIF)
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